Interpatient and intrapatient variability in vinblastine pharmacokinetics

Area of Science:

• Pharmacology
• Oncology
• Clinical Pharmacokinetics

Background:

• Vinblastine is a key chemotherapeutic agent.
• Understanding its pharmacokinetic variability is crucial for optimizing treatment.
• Previous studies have not fully elucidated the factors affecting vinblastine clearance over time.

Purpose of the Study:

• To analyze interpatient and intrapatient pharmacokinetic differences of vinblastine.
• To identify factors influencing vinblastine clearance during prolonged continuous infusion.
• To investigate the relationship between albumin levels, dose, and vinblastine elimination.

Main Methods:

• Pharmacokinetic analysis in 24 patients receiving bolus plus continuous infusion vinblastine.
• Measurement of serum vinblastine clearance and half-life.
• Correlation analysis of clearance with serum albumin levels and dose over time.

Main Results:

• Bolus clearance was 552 ml/min/m2; infusion clearance reached steady state at 646 ml/min/m2.
• Interpatient differences in albumin correlated with bolus and initial infusion clearance.
• Infusion clearance decreased significantly over 4 months (726 to 489 ml/min/m2), correlating positively with albumin and negatively with dose.

Conclusions:

• Interpatient and intrapatient variability in vinblastine pharmacokinetics is significant.
• Albumin levels and dose-dependent nonlinear elimination partially explain these pharmacokinetic differences.
• Hepatic function and drug dosage are critical determinants of vinblastine clearance.